Transition from selexipag to oral treprostinil in a patient with pulmonary arterial hypertension

Prostacyclins are the mainstay treatment for patients with severe pulmonary arterial hypertension. This case highlights the transition from selexipag to oral treprostinil. Our patient improved both subjectively and objectively. Cardiac output and index, as measured by the echocardiogram, improved 12...

Descripción completa

Detalles Bibliográficos
Autores principales: Oriaku, Ifeoma, Patel, Amol, Safdar, Zeenat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144673/
https://www.ncbi.nlm.nih.gov/pubmed/32292582
http://dx.doi.org/10.1177/2045894019898032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144673/
https://www.ncbi.nlm.nih.gov/pubmed/32292582
http://dx.doi.org/10.1177/2045894019898032

Ejemplares similares